{"drugs":["Benadryl","Benylin Decongestant Cough","Diphenhist","Diphenhydramine Hydrochloride","Diphenyl","Genahist","Geridryl","Nytol Quickcaps","Nytol Quickgels"],"mono":{"0":{"id":"183290-s-0","title":"Generic Names","mono":"Diphenhydramine Hydrochloride"},"1":{"id":"183290-s-1","title":"Dosing and Indications","sub":[{"id":"183290-s-1-4","title":"Adult Dosing","mono":"<ul><li><b>Allergic rhinitis:<\/b> 25 to 50 mg ORALLY every 4 to 6 h; maximum dose: 300 mg\/day  or 10 to 50 mg IM\/IV every 2 to 3 h; maximum parenteral dose: 400 mg\/day<\/li><li><b>Anaphylaxis; Adjunct:<\/b> in addition to epinephrine therapy, 25 to 50 mg ORALLY every 4 to 6 h or 10 to 50 mg IM\/IV (rate not to exceed 25 mg\/min) every 2 to 3 h; doses of 100 mg\/dose may be used if necessary; maximum parenteral dose: 400 mg\/day<\/li><li><b>Common cold:<\/b> 25 to 50 mg ORALLY every 4 to 6 h; maximum dose: 300 mg\/day<\/li><li><b>Insomnia:<\/b> 50 mg ORALLY at bedtime as needed<\/li><li><b>Motion sickness:<\/b> 10 to 50 mg IV\/IM (rate not to exceed 25 mg\/min); doses up to 100 mg\/dose may be used if necessary; MAX dose: 400 mg\/day<\/li><li><b>Motion sickness:<\/b> 25 to 50 mg ORALLY every 4 to 6 hr<\/li><li><b>Parkinsonism:<\/b> 10 to 50 mg IV\/IM (rate not to exceed 25 mg\/min); doses up to 100 mg\/dose may be used if necessary; MAX dose: 400 mg\/day<\/li><li><b>Pruritus of skin:<\/b> apply to affected area not more than 3 to 4 times daily<\/li><\/ul>"},{"id":"183290-s-1-5","title":"Pediatric Dosing","mono":"<ul><li>Not recommended in infants or neonates<\/li><li><b>Allergic rhinitis:<\/b> (up to 6 y) 6.25 to 12.5 mg ORALLY every 4 to 6 h<\/li><li><b>Allergic rhinitis:<\/b> (6 to 12 y) 12.5 to 25 mg ORALLY every 4 to 6 h; maximum dose: 150 mg\/day<\/li><li><b>Allergic rhinitis:<\/b> (12 y and older) 25 to 50 mg ORALLY every 4 to 6 h; maximum dose: 300 mg\/day<\/li><li><b>Allergic rhinitis:<\/b> 5 mg\/kg\/day or 150 mg\/m(2)\/day IM\/IV divided in 4 doses, MAX 300 mg\/day<\/li><li><b>Anaphylaxis; Adjunct:<\/b> in addition to epinephrine therapy, (up to 6 y) 6.25 to 12.5 mg ORALLY every 4 to 6 h<\/li><li><b>Anaphylaxis; Adjunct:<\/b> in addition to epinephrine therapy, (6 to 12 y) 12.5 to 25 mg ORALLY every 4 to 6 h; maximum dose: 150 mg\/day<\/li><li><b>Anaphylaxis; Adjunct:<\/b> in addition to epinephrine therapy, 5 mg\/kg\/day or 150 mg\/m(2)\/day IM\/IV (rate not to exceed 25 mg\/min) divided in 4 doses, MAX 300 mg\/day<\/li><li><b>Common cold:<\/b> (6 to 12 y) 12.5 to 25 mg ORALLY every 4 to 6 h; maximum dose: 150 mg\/day<\/li><li><b>Common cold:<\/b> (12 y and older) 25 to 50 mg ORALLY every 4 to 6 h; maximum dose: 300 mg\/day<\/li><li><b>Insomnia:<\/b> (12 y and older) 50 mg ORALLY at bedtime as needed<\/li><li><b>Motion sickness:<\/b> 5 mg\/kg\/day or 150 mg\/m(2)\/day divided into 4 doses (rate not to exceed 25 mg\/min); MAX dose: 300 mg\/day<\/li><li><b>Pruritus of skin:<\/b> apply to affected area not more than 3 to 4 times daily<\/li><\/ul>"},{"id":"183290-s-1-6","title":"Dose Adjustments","mono":"<ul><li><b>geriatrics:<\/b> initiate therapy at lower doses<\/li><li><b>renal impairment, mild:<\/b> GFR greater than 50 mL\/min, increase dosing interval to every 6 hours<\/li><li><b>renal impairment, moderate:<\/b> GFR 10-50 mL\/min, increase dosing interval to every 6-12 hours<\/li><li><b>renal impairment, severe:<\/b> GFR less than 10 mL\/min, increase dosing interval to every 12-18 hours<\/li><\/ul>"},{"id":"183290-s-1-7","title":"Indications","mono":"<b>FDA-Labeled Indications<\/b><ul><li>Allergic rhinitis<\/li><li>Anaphylaxis; Adjunct<\/li><li>Common cold<\/li><li>Insomnia<\/li><li>Motion sickness<\/li><li>Parkinsonism<\/li><li>Pruritus of skin<\/li><\/ul><b>Non-FDA Labeled Indications<\/b><ul><li>Chemotherapy-induced nausea and vomiting<\/li><li>Extrapyramidal disease - Medication-induced movement disorder<\/li><li>Hyperemesis gravidarum<\/li><li>Local anesthesia<\/li><\/ul>"}]},"3":{"id":"183290-s-3","title":"Contraindications\/Warnings","sub":[{"id":"183290-s-3-9","title":"Contraindications","mono":"<ul><li>hypersensitivity to diphenhydrAMINE<\/li><li>newborns or premature infants<\/li><li>nursing mothers<\/li><\/ul>"},{"id":"183290-s-3-10","title":"Precautions","mono":"<ul><li>bladder neck obstruction<\/li><li>concurrent MAOI therapy<\/li><li>concurrent use of central nervous system depressants<\/li><li>decreases mental alertness and psychomotor performance<\/li><li>do not use topical form on eyes or eye lids<\/li><li>elderly are more susceptible to the side effects of diphenhydrAMINE<\/li><li>history of bronchial asthma, increased intraocular pressure, hyperthyroidism, cardiovascular disease or hypertension<\/li><li>may cause excitation in young children<\/li><li>narrow angle glaucoma<\/li><li>pyloroduodenal obstruction<\/li><li>stenosing peptic ulcer<\/li><li>symptomatic prostatic hypertrophy<\/li><li>use of the topical form on patients with chicken pox, measles, blisters, or large areas of skin unless directed by a physician<\/li><\/ul>"},{"id":"183290-s-3-11","title":"Pregnancy Category","mono":"<ul><li>Diphenhydramine: B (FDA)<\/li><li>Diphenhydramine: A (AUS)<\/li><\/ul>"},{"id":"183290-s-3-12","title":"Breast Feeding","mono":"Diphenhydramine: Micromedex: Milk effects are possible.<br\/>"}]},"4":{"id":"183290-s-4","title":"Drug Interactions","sub":[{"id":"183290-s-4-13","title":"Contraindicated","mono":"<ul>Sodium Oxybate (theoretical)<\/ul>"},{"id":"183290-s-4-14","title":"Major","mono":"<ul><li>Buprenorphine (theoretical)<\/li><li>Bupropion (theoretical)<\/li><li>Carbinoxamine (theoretical)<\/li><li>Donepezil (theoretical)<\/li><li>Fentanyl (theoretical)<\/li><li>Hydrocodone (theoretical)<\/li><li>Hydromorphone (theoretical)<\/li><li>Linezolid (theoretical)<\/li><li>Meclizine (theoretical)<\/li><li>Methadone (theoretical)<\/li><li>Morphine (theoretical)<\/li><li>Morphine Sulfate Liposome (theoretical)<\/li><li>Oxycodone (theoretical)<\/li><li>Oxymorphone (probable)<\/li><li>Suvorexant (theoretical)<\/li><li>Tapentadol (theoretical)<\/li><li>Umeclidinium (theoretical)<\/li><li>Zolpidem (theoretical)<\/li><\/ul>"},{"id":"183290-s-4-15","title":"Moderate","mono":"<ul>Perampanel (probable)<\/ul>"}]},"5":{"id":"183290-s-5","title":"Adverse Effects","mono":"<b>Common<\/b><ul><li><b>Gastrointestinal:<\/b>Xerostomia<\/li><li><b>Neurologic:<\/b>Dizziness, Dyskinesia, Sedated<\/li><li><b>Psychiatric:<\/b>Somnolence<\/li><li><b>Respiratory:<\/b>Nasal mucosa dry, Pharyngeal dryness, Thick sputum, Bronchial<\/li><\/ul><b>Serious<\/b><br\/><b>Immunologic:<\/b>Anaphylaxis<br\/>"},"6":{"id":"183290-s-6","title":"Drug Name Info","sub":{"0":{"id":"183290-s-6-17","title":"US Trade Names","mono":"<ul><li>Benadryl<\/li><li>Benylin Decongestant Cough<\/li><li>Diphenhist<\/li><li>Diphenyl<\/li><li>Genahist<\/li><li>Geridryl<\/li><li>Nytol Quickcaps<\/li><li>Nytol Quickgels<\/li><\/ul>"},"2":{"id":"183290-s-6-19","title":"Class","mono":"<ul><li>Analgesic<\/li><li>Antihistamine<\/li><li>Antihistamine, Ethanolamine\/Acetaminophen Combination<\/li><li>Antipruritic<\/li><li>Antitussive\/Expectorant Combination<\/li><li>Ethanolamine (class)<\/li><li>Respiratory Agent<\/li><li>Sleep Aid<\/li><\/ul>"},"3":{"id":"183290-s-6-20","title":"Regulatory Status","mono":"RX\/OTC<br\/>"},"4":{"id":"183290-s-6-21","title":"Generic Availability","mono":"Yes<br\/>"}}},"7":{"id":"183290-s-7","title":"Mechanism Of Action","mono":"DiphenhydrAMINE hydrochloride acts as an antihistamine by competing with histamine for receptor sites on effector cells.<br\/>"},"8":{"id":"183290-s-8","title":"Pharmacokinetics","sub":{"1":{"id":"183290-s-8-24","title":"Distribution","mono":"Vd: widely distributed <br\/>"},"2":{"id":"183290-s-8-25","title":"Metabolism","mono":"Hepatic <br\/>"},"3":{"id":"183290-s-8-26","title":"Excretion","mono":"Renal <br\/>"}}},"9":{"id":"183290-s-9","title":"Administration","mono":"<ul><li><b>General Information<\/b><br\/>(IV, IM) for IV or IM administration only<br\/><\/li><li><b>Intramuscular<\/b><br\/>administer by deep IM injection<br\/><\/li><li><b>Intravenous<\/b><br\/><ul><li>adult: administer IV at a rate generally not exceeding 25 mg\/min<\/li><li>pediatric: administer IV at concentration of 50 mg\/mL or dilute in D5W or NS if necessary; give over 2 to 5 min or at maximum rate not to exceed 25 mg\/min<\/li><\/ul><\/li><li><b>Oral<\/b><br\/><ul><li>do not break capsules or softgels<\/li><li>(chewable tablets) chew thoroughly before swallowing<\/li><\/ul><\/li><\/ul>"},"10":{"id":"183290-s-10","title":"Monitoring","mono":"<ul><li>allergy: decreased rhinitis, urticaria, itchiness<\/li><li>insomnia: improved sleep<\/li><li>motion sickness\/nausea\/vomiting: improvement in nausea\/vomiting<\/li><li>Parkinson's: rigidity, tremor, gait disturbances<\/li><\/ul>"},"11":{"id":"183290-s-11","title":"How Supplied","mono":"<ul><li><b>Generic<\/b><br\/><ul><li>Injection Solution: 10 MG\/ML, 50 MG\/ML<\/li><li>Oral Capsule: 25 MG, 50 MG<\/li><li>Oral Elixir: 12.5 MG\/5 ML<\/li><li>Oral Solution: 12.5 MG\/5 ML<\/li><li>Oral Tablet: 25 MG, 50 MG<\/li><\/ul><\/li><li><b>Aler-Dryl<\/b><br\/>Oral Tablet: 50 MG<br\/><\/li><li><b>Aller-G-Time<\/b><br\/>Oral Tablet: 25 MG<br\/><\/li><li><b>Allergy Relief Medicine<\/b><br\/>Oral Capsule: 25 MG<br\/><\/li><li><b>Allergy Relief<\/b><br\/><ul><li>Oral Capsule: 25 MG<\/li><li>Oral Tablet: 25 MG<\/li><\/ul><\/li><li><b>Allermax<\/b><br\/><ul><li>Oral Solution: 12.5 MG\/5 ML<\/li><li>Oral Tablet: 50 MG<\/li><\/ul><\/li><li><b>Anti-Hist<\/b><br\/>Oral Capsule: 25 MG<br\/><\/li><li><b>Banaril<\/b><br\/>Injection Solution: 50 MG\/ML<br\/><\/li><li><b>Banophen<\/b><br\/><ul><li>Oral Capsule: 25 MG, 50 MG<\/li><li>Oral Elixir: 12.5 MG\/5 ML<\/li><li>Oral Tablet: 25 MG<\/li><\/ul><\/li><li><b>BD Simplist diphenhydrAMINE Hydrochloride<\/b><br\/>Injection Solution: 50 MG\/ML<br\/><\/li><li><b>Benadryl Allergy<\/b><br\/><ul><li>Oral Capsule, Liquid Filled: 25 MG<\/li><li>Oral Film: 25 MG<\/li><li>Oral Tablet: 25 MG<\/li><\/ul><\/li><li><b>Benadryl<\/b><br\/>Injection Solution: 50 MG\/ML<br\/><\/li><li><b>Benadryl Itch Stopping Gel<\/b><br\/>Topical Gel\/Jelly: 2 %<br\/><\/li><li><b>Children's Allergy<\/b><br\/>Oral Syrup: 12.5 MG\/5 ML<br\/><\/li><li><b>Children's Benadryl Allergy<\/b><br\/><ul><li>Oral Solution: 12.5 MG\/5 ML<\/li><li>Oral Syrup: 12.5 MG\/5 ML<\/li><li>Oral Tablet, Disintegrating: 12.5 MG<\/li><\/ul><\/li><li><b>Children's Triaminic Allergy<\/b><br\/>Mucous Membrane Film: 12.5 MG<br\/><\/li><li><b>Children's Triaminic Cough &amp; Runny Nose<\/b><br\/>Mucous Membrane Film: 12.5 MG<br\/><\/li><li><b>Children's Wal-Dryl Allergy<\/b><br\/>Oral Tablet, Disintegrating: 12.5 MG<br\/><\/li><li><b>Complete Allergy Medicine<\/b><br\/><ul><li>Oral Capsule: 25 MG<\/li><li>Oral Tablet: 25 MG<\/li><\/ul><\/li><li><b>Complete Allergy<\/b><br\/>Oral Elixir: 12.5 MG\/5 ML<br\/><\/li><li><b>Compoz Nighttime Sleep Aid<\/b><br\/>Oral Capsule, Liquid Filled: 50 MG<br\/><\/li><li><b>Dermamycin<\/b><br\/>Topical Cream: 2 %<br\/><\/li><li><b>Diphenhist<\/b><br\/><ul><li>Oral Capsule: 25 MG<\/li><li>Oral Solution: 12.5 MG\/5 ML<\/li><li>Oral Tablet: 25 MG<\/li><\/ul><\/li><li><b>Diphen<\/b><br\/>Oral Tablet: 25 MG<br\/><\/li><li><b>Diphenyl Elixir<\/b><br\/>Oral Elixir: 12.5 MG\/5 ML<br\/><\/li><li><b>Diphenyl<\/b><br\/>Oral Capsule: 25 MG<br\/><\/li><li><b>Dormin Sleep Aid<\/b><br\/>Oral Capsule: 25 MG<br\/><\/li><li><b>FusePaq Dicopanol<\/b><br\/>Oral Suspension: 5 MG\/ML<br\/><\/li><li><b>Geridryl<\/b><br\/>Oral Tablet: 25 MG<br\/><\/li><li><b>Good Neighbor Pharmacy Allergy<\/b><br\/>Oral Capsule: 25 MG<br\/><\/li><li><b>Good Neighbor Pharmacy Children's Allergy<\/b><br\/>Oral Solution: 12.5 MG\/5 ML<br\/><\/li><li><b>Good Neighbor Pharmacy Nighttime Sleep Aid<\/b><br\/>Oral Tablet: 25 MG<br\/><\/li><li><b>Good Sense Allergy Relief<\/b><br\/>Oral Tablet: 25 MG<br\/><\/li><li><b>Good Sense Children's Allergy Relief<\/b><br\/>Oral Solution: 12.5 MG\/5 ML<br\/><\/li><li><b>Good Sense Nighttime Sleep Aid<\/b><br\/>Oral Tablet: 25 MG<br\/><\/li><li><b>Histaprin<\/b><br\/>Oral Tablet: 25 MG<br\/><\/li><li><b>Nighttime Sleep Aid<\/b><br\/><ul><li>Oral Capsule, Liquid Filled: 50 MG<\/li><li>Oral Tablet: 25 MG<\/li><\/ul><\/li><li><b>Nytol QuickCaps<\/b><br\/>Oral Tablet: 25 MG<br\/><\/li><li><b>Nytol Quickgels Maximum Strength<\/b><br\/>Oral Capsule, Liquid Filled: 50 MG<br\/><\/li><li><b>Pharbedryl<\/b><br\/>Oral Capsule: 25 MG, 50 MG<br\/><\/li><li><b>Q-Dryl<\/b><br\/><ul><li>Oral Capsule: 25 MG<\/li><li>Oral Solution: 12.5 MG\/5 ML<\/li><\/ul><\/li><li><b>Quality Choice Complete Allergy Medicine<\/b><br\/>Oral Tablet: 25 MG<br\/><\/li><li><b>Quality Choice Rest Simply<\/b><br\/>Oral Tablet: 25 MG<br\/><\/li><li><b>Quality Choice Sleep Aid<\/b><br\/>Oral Capsule, Liquid Filled: 50 MG<br\/><\/li><li><b>Quenalin<\/b><br\/>Oral Solution: 12.5 MG\/5 ML<br\/><\/li><li><b>Rest Simply<\/b><br\/>Oral Tablet: 25 MG<br\/><\/li><li><b>Rite Aid Allergy Medication<\/b><br\/><ul><li>Oral Capsule: 25 MG<\/li><li>Oral Tablet: 25 MG<\/li><\/ul><\/li><li><b>Rite Aid Allergy<\/b><br\/>Oral Solution: 12.5 MG\/5 ML<br\/><\/li><li><b>Rite Aid Allergy Relief<\/b><br\/>Oral Tablet: 25 MG<br\/><\/li><li><b>Rite Aid Anti-Itch<\/b><br\/>Topical Gel\/Jelly: 2 %<br\/><\/li><li><b>Rite Aid Children's Allergy Relief<\/b><br\/><ul><li>Oral Solution: 12.5 MG\/5 ML<\/li><li>Oral Tablet, Disintegrating: 12.5 MG<\/li><\/ul><\/li><li><b>Rite Aid Nighttime Sleep<\/b><br\/>Oral Tablet: 25 MG<br\/><\/li><li><b>Rite Aid Sleep Aid<\/b><br\/><ul><li>Oral Capsule, Liquid Filled: 25 MG, 50 MG<\/li><li>Oral Elixir: 50 MG\/30 ML<\/li><li>Oral Tablet: 25 MG<\/li><\/ul><\/li><li><b>Serabrina LA France<\/b><br\/>Oral Liquid: 50 MG\/15 ML<br\/><\/li><li><b>Siladryl Allergy<\/b><br\/>Oral Solution: 12.5 MG\/5 ML<br\/><\/li><li><b>Silphen<\/b><br\/>Oral Syrup: 12.5 MG\/5 ML<br\/><\/li><li><b>Simply Sleep<\/b><br\/>Oral Tablet: 25 MG<br\/><\/li><li><b>Sleep Aid<\/b><br\/><ul><li>Oral Capsule, Liquid Filled: 50 MG<\/li><li>Oral Tablet: 25 MG<\/li><\/ul><\/li><li><b>Sleep-Ettes D<\/b><br\/>Oral Tablet: 50 MG<br\/><\/li><li><b>Sleepinal<\/b><br\/>Oral Capsule: 50 MG<br\/><\/li><li><b>Sominex<\/b><br\/>Oral Tablet: 25 MG, 50 MG<br\/><\/li><li><b>Sunmark Allergy Relief<\/b><br\/>Oral Tablet: 25 MG<br\/><\/li><li><b>TopCare Allergy<\/b><br\/><ul><li>Oral Capsule: 25 MG<\/li><li>Oral Tablet: 25 MG<\/li><\/ul><\/li><li><b>TopCare Children's Allergy<\/b><br\/>Oral Solution: 12.5 MG\/5 ML<br\/><\/li><li><b>TopCare Nighttime Sleep Aid<\/b><br\/>Oral Tablet: 25 MG<br\/><\/li><li><b>Truxadryl<\/b><br\/>Injection Solution: 10 MG\/ML, 50 MG\/ML<br\/><\/li><li><b>Twilite<\/b><br\/>Oral Tablet: 50 MG<br\/><\/li><li><b>Valu-Dryl Allergy<\/b><br\/><ul><li>Oral Capsule: 25 MG<\/li><li>Oral Tablet: 25 MG<\/li><\/ul><\/li><li><b>Valu-Dryl Anti-Itch<\/b><br\/>Topical Cream: 2 %<br\/><\/li><li><b>Vicks QlearQuil Nighttime Allergy Relief<\/b><br\/>Oral Tablet: 25 MG<br\/><\/li><li><b>Wal-Dryl Allergy<\/b><br\/><ul><li>Oral Capsule: 25 MG<\/li><li>Oral Tablet: 25 MG<\/li><\/ul><\/li><li><b>ZzzQuil<\/b><br\/><ul><li>Oral Capsule, Liquid Filled: 25 MG<\/li><li>Oral Elixir: 50 MG\/30 ML<\/li><\/ul><\/li><\/ul>"},"12":{"id":"183290-s-12","title":"Toxicology","sub":[{"id":"183290-s-12-31","title":"Clinical Effects","mono":"<b>DIPHENHYDRAMINE AND RELATED AGENTS <\/b><br\/>USES: DiphenhydrAMINE and dimenhyDRINATE are sedating antihistamines used to treat allergic conditions, motion sickness and are used as a sleep aid. Occasionally used as a drug of abuse. PHARMACOLOGY: Competitive antagonist of histamine at the H1 receptor. TOXICOLOGY: Anticholinergic (primarily antimuscarinic) effects develop in overdose. DimenhyDRINATE toxicity is similar in nature to diphenhydrAMINE toxicity. EPIDEMIOLOGY: Poisoning is common but rarely severe. May occur via oral, parenteral or dermal route. MILD TO MODERATE POISONING: Somnolence, anticholinergic effects (mydriasis, flushing, fever, dry mouth, urinary retention, decreased bowel sounds), tachycardia, mild hypertension, nausea and vomiting are common after overdose. Agitation, confusion and hallucinations may develop with moderate poisoning. SEVERE POISONING: Severe effects may include delirium, psychosis, seizures, coma, hypotension, QRS widening, and ventricular dysrhythmias, including torsades de pointe, but are generally  only reported in adults after ingestions of one gram or more of  diphenhydrAMINE. Rhabdomyolysis and renal failure may rarely develop in patients with prolonged agitation, coma or seizures. ADVERSE EFFECTS: Mild sedation, dizziness, impaired coordination, and mild anticholinergic effects are common, paradoxical excitation develops in some patients.<br\/>"},{"id":"183290-s-12-32","title":"Treatment","mono":"<b>DIPHENHYDRAMINE AND RELATED AGENTS <\/b><br\/><ul><li>Support: MANAGEMENT OF MILD TO MODERATE TOXICITY: The vast majority of diphenhydrAMINE overdoses require only supportive care; activated charcoal if patients present shortly after ingestion, and sedation with benzodiazepines for agitation and delirium. Hypertension and tachycardia are generally mild and well tolerated, and do not require specific treatment. Physostigmine can be used to establish the diagnosis if it may help avoid an invasive, costly work up, but should only be given in a setting where intensive monitoring and resuscitation is possible, and should NOT be given if the history or ECG (QRS widening) suggest tricyclic antidepressant poisoning. MANAGEMENT OF SEVERE TOXICITY: Orotracheal intubation for airway protection should be performed early. May benefit from gastric lavage if patient presents soon after a large (more than 1 gram) ingestion; administer activated charcoal (GI decontamination should be performed only in patients who can protect their airway or who are intubated). Severe delirium may develop and require large doses of benzodiazepines for sedation. Seizures (may progress to status epilepticus) may require aggressive use of benzodiazepines, propofol and\/or barbiturates. Monitor for QRS widening and ventricular dysrhythmias; treat with intravenous sodium bicarbonate (1 to 2 mEq\/kg IV bolus starting dose, titrate to blood pH 7.45 to 7.55), or lidocaine if sodium bicarbonate unsuccessful. Monitor core temperature and treat hyperthermia with aggressive benzodiazepine sedation to control agitation, and external cooling. Clinical manifestations may be prolonged due to prolonged absorption in the setting of anticholinergic ileus.<\/li><li>Decontamination: PREHOSPITAL: Prehospital gastrointestinal decontamination is not recommended because of potential for somnolence and seizures. HOSPITAL: Activated charcoal after large ingestion if patient able to protect airway; consider gastric lavage if recent, large (more than 1 g) ingestion, protect airway first. DERMAL: Soap and water.<\/li><li>Airway management: Perform early in patients with severe toxicity (coma, seizures, dysrhythmias, severe delirium).<\/li><li>Antidote: Physostigmine is indicated to reverse the CNS effects caused by clinical or toxic dosages of agents capable of producing anticholinergic syndrome; however, long lasting reversal of anticholinergic signs and symptoms is generally not achieved because of the relatively short duration of action of physostigmine (45 to 60 minutes).  It is most often used diagnostically to distinguish anticholinergic delirium from other causes of altered mental status. CAUTION: If tricyclic antidepressants are coingested, physostigmine may precipitate seizures and dysrhythmias. DOSES: ADULT: 2 mg IV at a slow controlled rate, no more than 1 mg\/min. May repeat doses at intervals of 10 to 30 min, if severe symptoms recur. For patients with prolonged anticholinergic delirium consider a continuous infusion, start at 2 mg\/hr and titrate to effect. CHILD: 0.02 mg\/kg by slow IV injection, at a rate no more than 0.5 mg\/minute. Repeat dosage at 5 to 10 minute intervals as long as the toxic effect persists and there is no sign of cholinergic effects. MAXIMUM DOSAGE: 2 mg total.<\/li><li>Delirium: Sedate patient with benzodiazepines; large doses may be required.<\/li><li>Ventricular arrhythmia: Obtain an ECG, institute continuous cardiac monitoring and administer oxygen. Evaluate for hypoxia, acidosis, and electrolyte disorders (particularly hypokalemia, hypocalcemia, and hypomagnesemia). Sodium bicarbonate is generally first-line therapy for QRS widening and ventricular dysrhythmias, administer 1 to 2 mEq\/kg, repeat as needed to maintain blood pH between 7.45 and 7.55. In patients unresponsive to bicarbonate, consider lidocaine.<\/li><li>Seizure: IV benzodiazepines, propofol, barbiturates.<\/li><li>Body temperature above reference range: Sedate to control agitation; aggressive external cooling.<\/li><li>Enhanced elimination procedure: Hemodialysis and hemoperfusion are not of value because of the large volume of distribution.<\/li><li>Patient disposition: HOME CRITERIA: Asymptomatic (other than mild drowsiness or stimulation) children less than 6 years of age with acute inadvertent ingestion of less than 7.5 mg\/kg may be monitored at home. Asymptomatic patients 6 years of age and older with acute inadvertent ingestions of less than 7.5 mg\/kg or 300 mg (whichever is less) may be monitored at home. Patients with inadvertent ingestions who are asymptomatic at the time of the call, and more than 4 hours have elapsed since the ingestion, can be managed at home, as can asymptomatic excessive dermal exposures where more than 8 hours have elapsed since exposure and the skin has been washed.  OBSERVATION CRITERIA: Children less than 6 years of age with ingestions of at least 7.5 mg\/kg should be sent to a healthcare facility. Patients 6 years of age and older with deliberate ingestions or those with ingestions of at least 7.5 mg\/kg or 300 mg total or more (whichever is less), and symptomatic patients should be sent to a healthcare facility for observation for 6 to 8 hours. Patients who manifest more than mild sedation or stimulation at the end of this period should be admitted to the hospital. ADMISSION CRITERIA: Patients with significant persistent central nervous system toxicity (hallucinations, somnolence, delirium, coma), or persistent tachycardia should be admitted. Patients with coma, seizures, dysrhythmias, or delirium should be admitted to an intensive care setting. CONSULT CRITERIA: A poison center or medical toxicologist for patients with severe poisoning (seizures, dysrhythmias, severe delirium, coma), or in whom the diagnosis is not clear.<\/li><\/ul>"},{"id":"183290-s-12-33","title":"Range of Toxicity","mono":"<b>DIPHENHYDRAMINE AND RELATED AGENTS<\/b><br\/>TOXICITY: In young children, ingestions of less than 7.5 mg\/kg are not expected to cause significant toxicity. ADULTS: Severe toxicity (ie, delirium, seizures, coma) generally develops only after  ingestion of one gram or more in adults. An adult developed ventricular dysrhythmias after 25 g; 25 mg\/kg was fatal in another adult. PEDIATRIC: Lowest lethal dose was 62.5 mg (11.6 mg\/kg) in an infant; severe toxicity has been reported at 10 to 15 mg\/kg. THERAPEUTIC DOSE ADULT: 25 to 100 mg orally every 6 hours; maximum daily dose 400 mg. PEDIATRIC: 5 mg\/kg\/day divided into 4 doses; maximum dose, 300 mg\/day.<br\/>"}]},"13":{"id":"183290-s-13","title":"Clinical Teaching","mono":"<ul><li>Young children may experience a paradoxical excitation effect.<\/li><li>Patient should avoid activities requiring mental alertness or coordination until drug effects are realized, as drug may cause drowsiness.<\/li><li>This drug may cause anticholinergic effects. Elderly patients may be more susceptible to these effects.<\/li><li>Patient should not use topical form on eyes or eyelid.<\/li><li>Instruct patient to avoid applying occlusive dressings, cosmetics, or other skin products over areas treated with topical formulation.<\/li><li>Patient should avoid concomitant use of MAO inhibitors or CNS depressants.<\/li><li>Patient should not drink alcohol while taking this drug.<\/li><\/ul>"}}}